Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors
…, A Gopher, S Almog, BR Martin, DR Compton… - Biochemical …, 1995 - Elsevier
In this study, we report the isolation from canine intestines of 2-arachidonyl glycerol (2-Ara-Gl).
Its structure was determined by mass spectrometry and by direct comparison with a …
Its structure was determined by mass spectrometry and by direct comparison with a …
Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands.
VM Showalter, DR Compton, BR Martin… - Journal of Pharmacology …, 1996 - ASPET
Two cannabinoid receptors have been identified to date; one is located predominantly in
the central nervous system (CB1), whereas the other is located exclusively in the periphery (…
the central nervous system (CB1), whereas the other is located exclusively in the periphery (…
Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors
…, K Varga, KD Lake, DR Compton… - Proceedings of the …, 1999 - National Acad Sciences
Cannabinoids, including the endogenous ligand arachidonyl ethanolamide (anandamide),
elicit not only neurobehavioral but also cardiovascular effects. Two cannabinoid receptors, …
elicit not only neurobehavioral but also cardiovascular effects. Two cannabinoid receptors, …
[PDF][PDF] Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities.
DR Compton, KC Rice, BR De Costa… - … of Pharmacology and …, 1993 - researchgate.net
Although a receptor exists for cannabinoid drugs, it is uncertain which pharmacological
actions this receptor mediates. This structure-activity relationship investigation was initiated to …
actions this receptor mediates. This structure-activity relationship investigation was initiated to …
Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs
BR Martin, DR Compton, BF Thomas… - Pharmacology …, 1991 - Elsevier
Numerous cannabinoids have been synthesized that are extremely potent in all of the
behavioral assays conducted in our laboratory. An important feature in increasing potency has …
behavioral assays conducted in our laboratory. An important feature in increasing potency has …
[PDF][PDF] The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice
PB Smith, DR Compton, SP Welch… - … of Pharmacology and …, 1994 - druglibrary.org
The arachidonic acid derivative anandamide (arachidonylethan-olamide) has been isolated
from porcine brain and has been shown to bind competitively to the cannabinoid receptor. …
from porcine brain and has been shown to bind competitively to the cannabinoid receptor. …
Design, synthesis and pharmacology of cannabimimetic indoles
JW Huffman, D Dai, BR Martin, DR Compton - Bioorganic & Medicinal …, 1994 - Elsevier
… to 19% yield All of the indoles were evaluated in virro by measuring their ability to displace
[3Hl CP-55,940 (2) from its binding site in a membrane preparation as described by Compton …
[3Hl CP-55,940 (2) from its binding site in a membrane preparation as described by Compton …
Pharmacology and stereoselectivity of structurally novel cannabinoids in mice.
PJ Little, DR Compton, MR Johnson, LS Melvin… - … of Pharmacology and …, 1988 - ASPET
The pharmacological effects of three stereoisomeric pairs of structurally novel cannabinoids
were tested after iv administration in mice for depression of spontaneous activity and the …
were tested after iv administration in mice for depression of spontaneous activity and the …
In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): inhibition of delta 9-tetrahydrocannabinol-induced responses and apparent …
DR Compton, MD Aceto, J Lowe, BR Martin - Journal of Pharmacology and …, 1996 - ASPET
SR141716A has been described as a cannabinoid receptor antagonist. This study was
conducted to determine whether SR141716A was capable of antagonizing the pharmacological …
conducted to determine whether SR141716A was capable of antagonizing the pharmacological …
Aminoalkylindole analogs: cannabimimetic activity of a class of compounds structurally distinct from delta 9-tetrahydrocannabinol.
DR Compton, LH Gold, SJ Ward, RL Balster… - … of Pharmacology and …, 1992 - ASPET
Six novel aminoalkylindole analogs, related structurally to the dual cyclooxygenase inhibitor
and nonopioid analgesic pravadoline, were evaluated in the mouse to determine whether …
and nonopioid analgesic pravadoline, were evaluated in the mouse to determine whether …